Renowned German company replaces legacy system with RxLogix NextGen Safety Platform - Rxlogix Renowned German company replaces legacy system with RxLogix NextGen Safety Platform - Rxlogix

Renowned German company replaces legacy system with RxLogix NextGen Safety Platform

Renowned German company replaces legacy system with RxLogix NextGen Safety Platform

17 Dec 2025

Problem Statement:

Lack of automation in case intake and case processing
Separate business processes for Aesthetics and Device Units within single system
Efficient handling of Device, Cosmetic and Drug Products in a system
Database performance issues
Manual updates within reports for Device information. Missing eMDR functionality.
Inadequate Vendor Support

Solution Implemented:

Implemented RxLogix’s Safety-in-a-Box (PV Case Management & PV Reports) separately for both Aesthetics & Device units
Data migration from one source system to two target systems (Aesthetics & Device units).
Configuration of NextGen reports for Device Vigilance
Device Compliance Support – EU MIR, FDA MedWatch, FDA eMDR Reports

100K+Cases for Migration | 10+ Adhoc & Aggregate Reports | 60+ Concurrent Users | 2 Intake Sources Automated

Milestone achieved:

Industry’s first Device setup for FDA’s latest Device MedWatch requirements
Decreased dependency on vendor support
Streamlined and automated intake
Improved System performance

RxLogix provides the industry's best solutions to the ever-changing drug safety & pharmacovigilance

BOOK A DEMO

eNewsletter/ Brochures/ White Papers

Subscribe to our newsletter and learn the latest news from RxLogix.

Sign Up

Get in touch with us

Information on RxLogix Products – info@rxlogix.com

RFI and RFP Response Request – sales@rxlogix.com

Sales Inquiries – sales@rxlogix.com

Marketing Inquiries – marketing@rxlogix.com

Career Opportunities – careers@rxlogix.com

Follow us

Connect with us

Copyright RxLogix 2026. All rights reserved